Combination of Asciminib plus Nilotinib or Asciminib plus Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results

被引：4

作者：

DeAngelo, Daniel J. ^{[1
]}

Mauro, Michael J. ^{[2
]}

Kim, Dong-Wook ^{[3
]}

Cortes, Jorge ^{[4
]}

Rea, Delphine ^{[5
]}

Hughes, Timothy P. ^{[6
,7
]}

Minami, Hironobu ^{[8
]}

Breccia, Massimo ^{[9
]}

Talpaz, Moshe ^{[10
]}

Hochhaus, Andreas ^{[11
]}

Goh, Yeow Tee ^{[12
]}

Le Coutre, Philipp D. ^{[13
]}

Sondhi, Manu ^{[14
]}

Mishra, Kaushal ^{[14
]}

Hourcade-Potelleret, Florence ^{[15
]}

Vanasse, Gary ^{[15
]}

Aimone, Paola ^{[15
]}

Lang, Fabian ^{[16
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Catholic Univ Korea, Seoul St Marys Hosp, Leukemia Res Inst, Seoul, South Korea

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Hop St Louis, Paris, France

[6] SA Pathol, Adelaide, SA, Australia

[7] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia

[8] Kobe Univ Hosp, Kobe, Hyogo, Japan

[9] Univ Roma La Sapienza, Rome, Italy

[10] Univ Michigan, Ann Arbor, MI 48109 USA

[11] Univ Klinikum Jena, Abt Hamatol Onkol, Jena, Germany

[12] Singapore Gen Hosp, Singapore, Singapore

[13] Charite Univ Med Berlin, Berlin, Germany

[14] Novartis Pharmaceut, E Hanover, NJ USA

[15] Novartis Pharma AG, Basel, Switzerland

[16] Goethe Univ Frankfurt Main, Frankfurt, Germany

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

asciminib; tyrosine kinase inhibitor; clinical trial; CML; chronic myelogenous leukemia;

D O I：

10.1016/j.clml.2019.07.236

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CML-102

引用

页码：S290 / S291

页数：3

共 50 条

[21] ASC2ESCALATE Trial in Progress: A Phase 2 Single-Arm Dose Escalation Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CMLCP) Previously Treated With 1 Prior Tyrosine Kinase Inhibitor (TKI) [J].

Sasaki, Koji ;

Mauro, Michael J. ;

Levy, Moshe Y. ;

Atallah, Ehab L. ;

Koller, Paul ;

Maegawa, Rodrigo ;

Damon, Andrea ;

Kumar, Julie ;

Khan, Mahmudul ;

Cortes, Jorge E. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S299-S299

[22] ASC4FIRST, a Pivotal Phase 3 Study of Asciminib (ASC) vs Investigator-Selected Tyrosine Kinase Inhibitors (IS-TKIs) in Newly Diagnosed Patients With Chronic Myeloid Leukemia (CML): Primary Results [J].

Cortes, Jorge E. ;

Andorsky, David J. ;

Issa, Ghayas C. ;

Hughes, Timothy P. ;

Hochhaus, Andreas ;

Takahashi, Naoto ;

Bombaci, Felice ;

Wang, Jianxiang ;

Kim, Dong-Wook ;

Kim, Dennis Dong Hwan ;

Mayer, Jiri ;

Goh, Yeow-Tee ;

le Coutre, Philipp ;

Kapoor, Shruti ;

McCulloch, Tracey ;

Malek, Kamel ;

Yau, Lillian ;

Ifrah, Sophie ;

Larson, Richard A. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S369-S370

[23] ASC4KIDS: A Multicenter, Open-Label, Phase 1b/2 Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) [J].

Hijiya, Nobuko ;

Heneghan, Mallorie ;

Kapoor, Shruti ;

Dhamal, Vishal ;

Hoch, Matthias ;

Descamps, Laurence ;

Cardoso, Ana Paula ;

Pollard, Jessica .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S346-S347

[24] Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST [J].

Takahashi, Naoto ;

Kikushige, Yoshikane ;

Nakamae, Hirohisa ;

Goto, Tatsunori ;

Tomita, Akihiro ;

Ichii, Michiko ;

Ito, Satoshi ;

Teshima, Takanori ;

Kirito, Keita ;

Ikezoe, Takayuki ;

Hatano, Kaoru ;

Tanaka, Hirokazu ;

Hiramoto, Nobuhiro ;

Osako, Ryohei ;

Aoki, Makoto ;

Malek, Kamel ;

Ueda, Yasunori .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,

[25] Responses With Asciminib Continue to Deepen Over Time in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs) in the Phase III ASCEMBL Study [J].

Mauro, Michael ;

Hochhaus, Andreas ;

Hughes, Timothy ;

Rea, Delphine ;

Boquimpani, Carla ;

Minami, Yosuke ;

Apperley, Jane ;

Garcia-Gutierrez, Valentin ;

Kapoor, Shruti ;

Espurz, Noemi ;

Dhamal, Vishal ;

Cortes, Jorge .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S340-S340

[26] ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI) [J].

Mauro, Michael J. ;

Boquimpani, Carla ;

Rea, Delphine ;

Hochhaus, Andreas ;

Maheshwari, Vikalp Kumar ;

Allepuz, Alex ;

Patwardhan, Pallavi ;

Wu, Ying ;

DeRosa, Michael ;

Minami, Yosuke .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S336-S336

[27] Nilotinib as frontline therapy for patients with newly diagnosed Ph plus chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd [J].

Nakamae, Hirohisa ;

Shibayama, Hirohiko ;

Kurokawa, Mineo ;

Fukuda, Tetsuya ;

Nakaseko, Chiaki ;

Kanda, Yoshinobu ;

Nagai, Tadashi ;

Ohnishi, Kazunori ;

Maeda, Yasuhiro ;

Matsuda, Akira ;

Amagasaki, Taro ;

Yanada, Masamitsu .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (05) :624-632

[28] A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib [J].

Tomassetti, Sarah ;

Lee, Jennifer ;

Qing, Xin .

CLINICAL CASE REPORTS, 2022, 10 (11)

[29] Asciminib After One Prior Tyrosine Kinase Inhibitor (TKI) in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Real-World Chart Review Study in the United States (US) [J].

Atallah, Ehab L. ;

Sadek, Islam ;

Wei, David ;

Latremouille-Viau, Dominick ;

Rossi, Carmine ;

Damon, Andrea ;

Yang, Daisy ;

Bellefleur, Remi ;

Guerin, Annie ;

Jadhav, Kejal .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S365-S365

[30] Health care resource utilization in 3L+patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib [J].

Cortes, Jorge E. ;

Rea, Delphine ;

Mauro, Michael J. ;

Tran, Diana ;

Wang, Pearl ;

Jadhav, Kejal ;

Yocolly, Aurore ;

Sasaki, Koji .

JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) :915-923

← 1 2 3 4 5 →